Pulmonary capillaritis and alveolar hemorrhage: Update on diagnosis and management

Chest

Volumn 110, Issue 5, 1996, Pages 1305-1316

  Green, Ronald J ^a   Ruoss, Stephen J ^a   Kraft, Sally A ^a   Berry, Gerald J ^a   Raffin, Thomas A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antineutrophil cytoplasmic antibodies; diffuse alveolar hemorrhage; pulmonary capillaritis; review; vasculitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHENYTOIN; PREDNISONE;

ADULT; ANAPHYLACTOID PURPURA; ANTIPHOSPHOLIPID SYNDROME; CLINICAL ARTICLE; FEMALE; FIBEROPTIC BRONCHOSCOPY; GOODPASTURE SYNDROME; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INTRAVENOUS DRUG ADMINISTRATION; LABORATORY TEST; LUNG CAPILLARY; LUNG HEMORRHAGE; MALE; PATHOGENESIS; PNEUMOCYSTIS PNEUMONIA; POLYARTERITIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0029797787     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.5.1305     Document Type: Review

References (69)

1. Leavitt RY, Fanci AS. Pulmonary vasculitis. Am Rev Respir Dis 1986; 134:149-66
2. Fauci AS, Haynes BF, Katz P. The spectrum of vasculitis. Ann Intern Med 1978; 89:660-76
3. Myers JL, Katzenstein AA. Wegener's granulomatosis presenting with massive pulmonary hemorrhage and capillaritis. Am J Surg Pathol 1987; 11:895-98
4. Mark EJ, Ramirez JF. Pulmonary capillaritis and hemorrhage in patients with systemic vasculitis. Arch Pathol Lab Med 1985; 109:413-18
5. Imoto EM, Lombard CM, Sachs DPL. Pulmonary capillaritis and hemorrhage: a clue to the diagnosis of systemic necrotizing vasculitis. Chest 1989; 96:927-28
6. Travis WD, ColbyTV, Lombard C, et al. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol 1990; 14:1112-25
7. Travis WD, Carpenter HA, Lie JT. Diffuse pulmonary hemorrhage. Am J Surg Pathol 1987; 11:702-08
8. Leatherman JW, Sibley RK, Davies SF. Diffuse intrapulmonary hemorrhage and glomerulonephritis unrelated to anti-glomerular basement membrane antibody. Am J Med 1982; 72:401-10
9. Leatherman JW, Davies SF, Hoidal JR. Alveolar hemorrhage syndromes. Medicine 1984; 63:343-61
10. Savage COS, Winearls CG, Evans DJ, et al. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 1985; 56:467-83
11. Myers JL, Katzenstein AA. Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol 1986; 85:552-56
12. Lombard CM, Colby TV, Elliott CG. Surgical pathology of the lung in anti-basement membrane antibody-associated Goodpasture's syndrome. Hum Pathol 1989; 20:445-51
13. Churg A, Franklin W, Chan KL, et al. Pulmonary hemorrhage and immune-complex deposition in the lung. Arch Pathol Lab Med 1980; 104:388-91
14. Odeh M, Best L-A, Kerner H, et al. Localized Wegener's granulomatosis relapsing as diffuse massive intra-alveolar hemorrhage. Chest 1993; 104:955-56
15. Fauci AS, Haynes BF, Katz P, et al. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98:76-85
16. Rao JK, Weinberger M, Oddone EZ, et al. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. Ann Intern Med 1995; 123:925-32
17. Jennette JC, Falk RJ. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis 1990; 15:517-29
18. Gross WL, Csernok E. Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheumatol 1995; 7:11-9
19. Bosch X, López-Soto A, Mirapeix E, et al. Antineutrophil cytoplasmic autoantibdy-associated alveolar capillaritis in patients presenting with pulmonary hemorrhage. Arch Pathol Lab Med 1994; 118:517-22
20. Yoshimura N, Matsubara O, Tamura A, et al. Wegener's granulomatosis associated with diffuse pulmonary hemorrhage. Acta Pathol Japonica 1992; 42:657-61
21. Stokes TC, McCann BG, Rees RT, et al. Acute fulminating intrapulmonary haemorrhage in Wegener's granulomatosis. Thorax 1982; 37:315-16
22. Travis WD, Hoffman GS, Leavitt RY, et al. Surgical pathology of the lung in Wegener's granulomatosis. Am J Surg Pathol 1991; 15:315-33
23. Yoshikawa Y, Watanabe T. Capillaritis and pulmonary hemorrhage in Wegener's granulomatosis [letter]. Am J Surg Pathol 1989; 13:78
24. Shasby DM, Schwarz MI, Forstot JZ, et al. Pulmonary immune complex deposition in Wegener's granulomatosis. Chest 1982; 81:338-40
25. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116:488-98
26. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Arthritis Rheum 1994; 37:187-92
27. Kallenberg CGM, Mulder AHL, Tervaert JWC. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med 1992; 93:675-82
28. Thomashow BM, Felton CP, Navarro C. Diffuse intrapulmonary hemorrhage, renal failure and a systemic vasculitis. Am J Med 1980; 68:299-304
29. Schwarz MI, Mortenson RL, Colby TV, et al. Pulmonary capillaritis: the association with progressive irreversible airflow limitation and hyperinflation. Am Rev Respir Dis 1993; 148:507-11
30. Carette S, Macher AM, Nussbaum A, et al. Severe, acute pulmonary disease in patients with systemic lupus erythematosus. Semin Arthritis Rheum 1984: 14:52-9
31. Haupt HM, Moore GW, Hutchins GM. The lung in systemic lupus erythematosus. Am J Med 1981; 71:791-98
32. Brasington RD, Furst DE. Pulmonary disease in systemic lupus erythematosus. Clin Exp Rheumatol 1985; 3:269-76
33. Wu M-J, Rajaram R, Shelp WD, et al. Vasculitis in Goodpasture's syndrome. Arch Pathol Lab Med 1980; 104:300-02
34. Wilson CB. Immunologic diseases of the lung and kidney (Goodpasture's syndrome). In: Fishman AP, ed. Pulmonary diseases and disorders (vol 1). 2nd ed. New York: McGraw-Hill, 1988; 675-81
35. Sánchez M, Bosch X, Martinez C, et al. Idiopathic pulmonaryrenal syndrome with antiproteinase 3 antibodies. Respiration 1994; 61:295-99
36. Bosch X, Mirapeix E, Font J, et al. Anti-myeloperoxidase autoantibodies in patients with necrotizing glomerular and alveolar capillaritis. Am J Kidney Dis 1992; 20:231-39
37. Bosch X, Font J, Mirapeix E, et al. Antimyeloperoxidase autoantibody-associated necrotizing alveolar capillaritis. Am Rev Respir Dis 1992; 146:1326-29
38. Gamble CN, Wiesner KB, Shapiro RF. The immune complex pathogenesis of glomerulonephritis arid pulmonary vasculitis in Behçet's disease. Am J Med 1979; 66:1031-39
39. Slavin RE, deGroot WJ. Pathology of the lung in Behçet's disease. Am J Surg Pathol 1981; 5:779-88
40. Markus HS, Clark JV. Pulmonary haemorrhage in Henoch-Schönlein purpura. Thorax 1989; 44:525-26
41. Kathuria S, Cheifec G. Fatal pulmonary Henoch-Schönlein syndrome. Chest 1982; 82:654-56
42. Lai FM-M, Li EKM, Suen MWM, et al. Pulmonary hemorrhage: a fatal manifestation of IgA nephropathy. Arch Pathol Lab Med 1994; 118:542-46
43. Gertner E, Lie JT. Pulmonary capillaritis, alveolar hemorrhage and recurrent microvascular thrombosis in primary antiphospholipid syndrome. J Rheumatol 1993; 20:1224-28
44. Sieber SC, Cuello B, Gelfman NA, et al. Pulmonary capillaritis and glomerulonephritis in an antineutrophil cytoplasmic antibody-positive patient with prior granulomtous aortitis. Arch Pathol Lab Med 1990; 114:1223-26
45. Griffin MT, Robb JD, Martin JR. Diffuse alveolar haemorrhage associated with progressive systemic sclerosis. Thorax 1990; 45:903-04
46. Louie S, Gamble CN, Cross CE. Penicillamine associated pulmonary hemorrhage. J Rheumatol 1986; 13:963-66
47. Yermakov VM, Hitti IF, Sutton AL. Necrotizing vasculitis associated with diphenylhydantoin: two fatal cases. Hum Pathol 1983; 13:182-84
48. Cochrane CG, Weigle WO, Dixon FJ. The role of polymorphonuclear leukocytes in the initiation and cessation of the Arthus vaculitis. J Exp Med 1959; 110:481-94
49. Jennette JC, Falk RJ. Pathogenic potential of anti-neutrophil cytoplasmic autoantibodies. In: Gross WL, ed. ANCA-associated vasculitides: immunological and clinical aspects. New York: Plenum Press, 1993; 7-15
50. Falk RJ, Terrell RS, Charles LA, et al. Anti-neutrophil cytoplasmic antoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87:4115-19
51. Savage C, Gaskin G, Pusey CD, et al. Myeloperoxidase binds to vascular endothelial cells, is recognized by ANCA and can enhance complement dependent cytotoxicity. In: Gross WL, ed. ANCA-associated vasculitides: immunological and clinical aspects. New York: Plenum Press, 1993; 121-23
52. Morgan PGM, Turner-Warwick M. Pulmonary haemosiderosis and pulmonary hemorrhage. Br J Dis Chest 1981; 75:225-42
53. Primack SL, Miller RK, Müller NL. Diffuse pulmonary hemorrhage: clinical, pathologic, and imaging features. Am J Radiol 1995; 164:295-300
54. Albelda SM, Gefter WB, Epstein DM, et al. Diffuse pulmonary hemorrhage: a review and classification. Radiology 1985; 154:289-97
55. Müller NL, Miller RR. Diffuse pulmonary hemorrhage. Radiol Clin North Am 1991; 29:965-71
56. Bates DV. Respiratory function in disease. 3rd ed. Philadelphia: WB Saunders, 1989
57. Clark EH, Jones HA, Hughes JMB. Bedside rebreathing technique for measuring carbon monoxide uptake by the lung. Lancet 1978; 1:791-93
58. Savage COS, Winearls CG, Jones S, et al. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet 1987; 1:1389-93
59. Gaudin PB, Askin FB, Falk RJ, et al. The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol 1995; 104:7-16
60. Davenport A, Lock RJ, Wallington TB. Clinical relevance of testing for antineutrophil cytoplasm antibodies (ANCA) with a standard indirect immunofluorescence ANCA test in patients with upper and lower respiratory tract symptoms. Thorax 1994; 49:213-17
61. DeClerk LS, VanOffel JF, Smolders WA, et al. Pitfalls with antineutrophil cytoplasmic antibodies (ANCA). Clin Rheumatol 1989; 8:512-16
62. Shoenfeld Y, Andre-Schwartz J, Stollar BD, et al. Anti-DNA antibodies. In: Lahita RG, ed. Systemic lupus erythematosus. New York: John Wiley, 1987; 213-55
63. Wilson CB, Dixon FJ. Renal injury from immune reactions involving antigens in or of the kidney. In: Brenner BM, Stein J, eds. Contemporary issues in nephrology (vol 3). New York: Churchill Livingstone, 1979; 35-66
64. Johnson JP, Moore J Jr, Austin HA III, et al. Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine 1985; 64:219-27
65. Hellmann DB, Petri M, Whiting-O'Keefe Q. Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine 1987; 66:341-48
66. Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illnesses and prior corticosteroid therapy. Mayo Clin Proc 1996; 71:5-13
67. Sen RP, Walsh TE, Fisher W, et al. Pulmonary complications of combination therapy with cyclophosphamide and prednisone. Chest 1991; 99:143-46
68. Sepkowitz KA. Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome: who should receive prophylaxis? Mayo Clin Proc 1996; 71:102-03
69. Sepkowitz KA. Pneumocystis carinii pneumonia in patients without AIDS. Clin Infect Dis 1993; 17(suppl 2):S416-22